Enfiera 100 mg Injection
74,94$
58,45$
Enfiera 100 mg injection is a powerful monoclonal antibody that plays a crucial role in managing various immune-related conditions, particularly targeting specific cancers such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia. By selectively binding to certain proteins on cancer cells, Enfiera works to inhibit their growth and proliferation, effectively supporting the body’s immune response in the fight against these malignancies. While this treatment can be life-changing for many patients, it is essential to be aware of potential side effects, including infusion reactions and increased risk of infections, which may arise due to its impact on the immune system. Regular monitoring and communication with your healthcare provider are vital to ensure the best outcomes during therapy. Enfiera is administered via injection, allowing for a direct approach in delivering this targeted treatment. This innovative therapy exemplifies the advancements in cancer treatment, offering hope to those diagnosed with challenging immune-related disorders. As with any medication, always discuss your medical history and current medications with your healthcare professional before starting Enfiera. By understanding how Enfiera works and its associated risks, patients can make informed decisions about their cancer treatment journey.
Quantité
Active Pharmaceutical Ingredient
Uses
• Enfiera 100 mg injection is primarily used in the treatment of non-Hodgkin lymphoma (NHL), a type of cancer that affects the lymphatic system. This medication helps to target and reduce the proliferation of malignant cells in patients diagnosed with NHL. By administering Enfiera 100 mg injection, healthcare providers aim to improve patient outcomes and manage symptoms associated with this condition. Its role in the treatment regimen can be crucial for enhancing the quality of life in affected individuals.
• Another significant use of Enfiera 100 mg injection is in managing rheumatoid arthritis, a chronic inflammatory disorder. The medication aids in reducing inflammation and pain, allowing patients to regain better mobility and function. When prescribed Enfiera 100 mg injection, patients often experience a decrease in joint swelling and tenderness. This can lead to improved daily activities and overall well-being.
• Enfiera 100 mg injection is also indicated for the treatment of chronic lymphocytic leukemia (CLL), a type of blood cancer characterized by the accumulation of abnormal lymphocytes. By using Enfiera 100 mg injection, oncologists can help control the progression of CLL and manage its symptoms effectively. The medication works by targeting the cancerous cells, thus supporting the patient's immune response. This targeted approach is essential for achieving better treatment outcomes in CLL patients.
• In addition to its cancer treatment applications, Enfiera 100 mg injection is utilized for conditions such as granulomatosis with polyangiitis and microscopic polyangiitis. These are autoimmune disorders that cause inflammation of blood vessels, leading to various complications. Enfiera 100 mg injection helps in moderating the immune response, reducing inflammation, and preventing further damage to the affected tissues. This therapeutic action is vital for improving patient health and managing chronic symptoms associated with these conditions.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Enfiera 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Enfiera 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Enfiera 100 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Enfiera 100 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Enfiera 100 mg Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Enfiera 100 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Enfiera 100 Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Enfiera 100 mg. Please consult your doctor.
• Kidney: Enfiera 100 mg Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Enfiera 100 mg Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Enfiera 100 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Enfiera 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Enfiera 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.